Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target

Kuan Chung Hsiao, Neng Yao Shih, Hsun Lang Fang, Tze Sing Huang, Ching Chuan Kuo, Pei Yi Chu, Yi Mei Hung, Shao Wen Chou, Yi Yuan Yang, Gee Chen Chang, Ko Jiunn Liu

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

In previous research, we found α-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected α-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface α-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that α-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by α-enolase-specific antibody. α-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against α-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of α-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of α-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface α-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface α-enolase is a promising approach to suppress tumor metastasis.

Original languageEnglish
Article numbere69354
JournalPLoS One
Volume8
Issue number7
DOIs
Publication statusPublished - Jul 19 2013

Fingerprint

phosphopyruvate hydratase
Phosphopyruvate Hydratase
extracellular matrix
metastasis
Extracellular Matrix
Tumors
Neoplasm Metastasis
Degradation
therapeutics
neoplasms
degradation
lung neoplasms
Neoplasms
Lung Neoplasms
Cells
Therapeutics
u-plasminogen activator
plasminogen
antibodies
Antibodies

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Hsiao, K. C., Shih, N. Y., Fang, H. L., Huang, T. S., Kuo, C. C., Chu, P. Y., ... Liu, K. J. (2013). Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target. PLoS One, 8(7), [e69354]. https://doi.org/10.1371/journal.pone.0069354

Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target. / Hsiao, Kuan Chung; Shih, Neng Yao; Fang, Hsun Lang; Huang, Tze Sing; Kuo, Ching Chuan; Chu, Pei Yi; Hung, Yi Mei; Chou, Shao Wen; Yang, Yi Yuan; Chang, Gee Chen; Liu, Ko Jiunn.

In: PLoS One, Vol. 8, No. 7, e69354, 19.07.2013.

Research output: Contribution to journalArticle

Hsiao, KC, Shih, NY, Fang, HL, Huang, TS, Kuo, CC, Chu, PY, Hung, YM, Chou, SW, Yang, YY, Chang, GC & Liu, KJ 2013, 'Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target', PLoS One, vol. 8, no. 7, e69354. https://doi.org/10.1371/journal.pone.0069354
Hsiao, Kuan Chung ; Shih, Neng Yao ; Fang, Hsun Lang ; Huang, Tze Sing ; Kuo, Ching Chuan ; Chu, Pei Yi ; Hung, Yi Mei ; Chou, Shao Wen ; Yang, Yi Yuan ; Chang, Gee Chen ; Liu, Ko Jiunn. / Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target. In: PLoS One. 2013 ; Vol. 8, No. 7.
@article{863ea3a2ec174c01ab9ffe610e0d65a1,
title = "Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target",
abstract = "In previous research, we found α-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected α-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface α-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that α-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by α-enolase-specific antibody. α-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against α-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of α-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of α-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface α-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface α-enolase is a promising approach to suppress tumor metastasis.",
author = "Hsiao, {Kuan Chung} and Shih, {Neng Yao} and Fang, {Hsun Lang} and Huang, {Tze Sing} and Kuo, {Ching Chuan} and Chu, {Pei Yi} and Hung, {Yi Mei} and Chou, {Shao Wen} and Yang, {Yi Yuan} and Chang, {Gee Chen} and Liu, {Ko Jiunn}",
year = "2013",
month = "7",
day = "19",
doi = "10.1371/journal.pone.0069354",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target

AU - Hsiao, Kuan Chung

AU - Shih, Neng Yao

AU - Fang, Hsun Lang

AU - Huang, Tze Sing

AU - Kuo, Ching Chuan

AU - Chu, Pei Yi

AU - Hung, Yi Mei

AU - Chou, Shao Wen

AU - Yang, Yi Yuan

AU - Chang, Gee Chen

AU - Liu, Ko Jiunn

PY - 2013/7/19

Y1 - 2013/7/19

N2 - In previous research, we found α-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected α-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface α-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that α-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by α-enolase-specific antibody. α-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against α-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of α-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of α-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface α-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface α-enolase is a promising approach to suppress tumor metastasis.

AB - In previous research, we found α-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected α-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface α-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that α-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by α-enolase-specific antibody. α-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against α-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of α-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of α-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface α-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface α-enolase is a promising approach to suppress tumor metastasis.

UR - http://www.scopus.com/inward/record.url?scp=84880429753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880429753&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0069354

DO - 10.1371/journal.pone.0069354

M3 - Article

C2 - 23894455

AN - SCOPUS:84880429753

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e69354

ER -